Arcoverde E

Dissociation and antidepressant response to subcutaneous esketamine: A clinical study.

Gonçalves KTDC, Tavares VDO, Palhano-Fontes F +12

Europe PMC2026

Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: The role of baseline C-reactive protein.

Cavalcanti-Ribeiro P, De Souza LCAM, de Tavares VDO +11

Europe PMC2026

ArticlePsilocybin

Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.

Falchi-Carvalho M, Palhano-Fontes F, Wießner I +21

The Antidepressant Effects of Vaporized <i>N</i>,<i>N</i>-Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant Depression.

Falchi-Carvalho M, Barros H, Bolcont R +16

Ketamine-induced altered states of consciousness: a systematic review of implications for therapeutic outcomes in psychiatric practices.

da Costa Gonçalves KT, de Tavares VDO, de Morais Barros ML +9

Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study.

Palhano-Fontes F, Cavalcanti-Ribeiro P, da Costa Gonçalves KT +13

PreprintAyahuasca

The antidepressant effects of vaporized N,N-Dimethyltryptamine: a preliminary report in treatment-resistant depression

Falchi-Carvalho M, Barros H, Bolcont R +15

Europe PMC2024

ArticlePsilocybin

Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.

Falchi-Carvalho M, Wießner I, Silva SRB +15

Europe PMC2024

Ayahuasca for the Treatment of Depression.

Palhano-Fontes F, Soares BL, Galvão-Coelho NL +2

Europe PMC2022

The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial.

Zeifman RJ, Palhano-Fontes F, Hallak J +3

Europe PMC2019

Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.

Palhano-Fontes F, Barreto D, Onias H +20

Europe PMC2019